Skip to main content
Anke van den Berg
prof. dr.

I work as a clinical molecular biologist in the department of Pathology. In this function I supervise and implement advanced molecular diagnostic techniques. Within my research line, I focus on the molecular pathogenesis of B-cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are genomic aberrations, genetic susceptibility, and the role of small and long noncoding RNAs. I have several international collaborations and am PI and co-PI in various projects.

Value of RT-PCR analysis of sentinel nodes in determining the pathological nodal status in colon cancer
Background: Pathological examination of sentinel lymph nodes (SLNs) and non-SLNs in colon cancer is frequently not performed to the same extent. We examined whether non-SLNs were truly negative in tumors with tumor-negative SLNs using reverse transcriptase-polymerase chain reaction (RT-PCR). Patients and Methods: RT-PCR with carcinoembryonic antigen (CEA) was performed in hematoxylin-eosin (H&E) and immunohistochemical (IHC) tumor-negative SLNs. In RT-PCR negative SLNs, we also performed RT-PCR on non-SLNs. Statistical analyses indicated the requirement for a minimum of 72 accurate comparisons of non- SLNs and SLNs, which could be fulfilled...
Wendy Kelder, Andries Braat, Anke Van den Berg, Inge Platteel, Harry Hollema, Henk. Groen, John Plukker
Strongly enhanced IL-10 production using stable galectin-1 homodimers
Published in: Molecular Immunology
Galectin-1 is the homodimeric form of a protein, which is present in a dynamic equilibrium with the beta-galactoside monomeric form and has potent anti-inflammatory and immunomodulating effects. These favorable effects are probably related to the induction of apoptosis in activated T cells and the induction of IL-10, which have been demonstrated to be characteristic for the dimeric form of the protein. Based on these findings it can be speculated that the in vivo effects of galectin-1 can be improved by the generation of stable galectin-1 homodimers (dGal). To...
Judith van der Leij, Anke van den Berg, Geert Harms, Hugo Eschbach, Hans Vos, Peter Zwiers, Rob van Weeghel, Herman Groen, Sibrand Poppema, Lydia Visser
The human leukocyte antigen class I region is associated with EBV-positive Hodgkin’s lymphoma: HLA-A and HLA complex group 9 are putative candidate genes
Published in: Cancer Epidemiology, Biomarkers & Prevention
Various studies have indicated that the human leukocyte antigen (HLA) region is associated with Hodgkin’s lymphoma. We recently showed a specific association of the HLA class I region with EBV-positive Hodgkin’s lymphoma cases. One haplotype of two consecutive microsatellite markers (D6S265 and D6S510) was overrepresented in the patient group, whereas another haplotype was underrepresented. Here, we did fine mapping of this region of -400 kb as a next step to find the causative single-nucleotide polymorphism(s) (SNP). To select candidate SNPs for screening the total study population, several known...
Marijke Niens, Anke van den Berg, Arjan Diepstra, Ilja M. Nolte, Gerrit van der Steege, Alice Gallagher, G. Malcolm Taylor, Ruth F. Jarrett, Sibrand Poppema, Gerard J. te Meerman
The role of microRNAs in normal hematopoiesis and hematopoietic malignancies
Published in: Leukemia
Over the past few years, it has become evident that microRNAs ( miRNAs) play an important regulatory role in various biological processes. Much effort has been put into the elucidation of their biogenesis, and this has led to the general concept that a number of key regulators are shared with the processing machinery of small interfering RNAs. Despite the recognition that several miRNAs play crucial roles in normal development and in diseases, little is known about their exact molecular function and the identity of their target genes. In...
Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma
Published in: Genes Chromosomes & Cancer
Despite the fact that numerous studies have been performed on diffuse large B-cell lymphoma (DLBCL), only few have concerned extranodal lymphomas occurring in the testis. We performed a cytogenetic and molecular study of 17 testicular non-Hodgkin lymphomas, of which 14 were proven primary DLBCL of the testis. Cytogenetic analysis revealed in 8 out of 11 evaluable cases a structural abnormality of the long arm of chromosome 6, with deletion or addition of material of unknown origin, and with breakpoints spanning the region 6q12-6q23. The cytogenetic findings were confirmed...
Anneke G. Bosga-Bouwer, Klaas Kok, Marije Booman, Ludolf Boven, Pieter van der Vlies, Anke van den Berg, Eva van den Berg, Bauke de Jong, Sibrand Poppema, Philip Kluin